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Objective: To examine the impact of genetic, inflammatory, cardiovascular, lifestyle,
and neuroanatomical factors on cognitive processing speed (CPS) change over time in
functionally intact older adults.
Methods: This observational study conducted over two time points, included 120
community dwelling cognitively normal older adults between the ages of 60 and 80 from
the University of California San Francisco Memory and Aging Center. Participants were
followed with composite measures of CPS, calculated based on norms for 20–30 year-
olds. Variables of interest were AD risk genes (APOE, CR1), markers of inflammation
(interleukin 6) and cardiovascular health (BMI, LDL, HDL, mean arterial pressure, fasting
insulin), self-reported physical activity, and corpus callosum (CC) volumes. The sample
was divided into three groups: 17 “resilient-agers” with fast and stable processing
speed; 56 “average-agers” with average and stable processing speed; and 47 “sub-
agers” with average baseline speed who were slower at follow-up.
Results: Resilient-agers had larger baseline CC volumes than sub-agers (p < 0.05).
Resilient-agers displayed lower levels of interleukin-6 (IL-6) and insulin (ps < 0.05)
than sub-agers, and reported more physical activity than both average- and sub-agers
(ps < 0.01). In a multinomial logistic regression, physical activity and IL-6 predicted
average- and sub-ager groups. Resilient-agers displayed a higher frequency of APOE
e4 and CR1 AA/AG alleles.
Conclusion: Robust and stable CPS is associated with larger baseline CC volumes,
lower levels of inflammation and insulin, and greater self-reported physical activity. These
findings highlight the relevance of neuroanatomical, biological, and lifestyle factors in the
identification and prediction of heterogeneous cognitive aging change over time.
Keywords: processing speed, cognitive aging predictors, APOE E4 allele, white matter, IL-6, insulin, physical
exercise
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INTRODUCTION
Cognitive processing speed (CPS) reaches its zenith during early
adulthood (Salthouse, 1996) and declines from midlife onward
(Salthouse, 2009), with age-related cognitive slowing widely
reported (Cerella and Hale, 1994; Jenkins et al., 2000). Moreover,
CPS is a uniquely strong predictor of age-related cognitive
declines among older adults, including those needing help with
activities of daily living (Salthouse and Ferrer-Caja, 2003; Wahl
et al., 2010). Nevertheless, there is considerable variability in the
degree to which cognitive functioning changes with age, and
recent studies have identified a small number of individuals,
who appear resilient against such age-related cognitive decline
within the specific domain of episodic memory (Rogalski et al.,
2013; Gefen et al., 2014, 2015; Sun et al., 2016). Whether similar
resilience exists within different cognitive domains is unknown.
This study sought to identify and characterize individuals
resilient to age-related slowing in CPS over time.
Biological aging models posit upstream causal factors such
as lifestyle variables and genetics interacting with inflammatory
status and vascular health to affect downstream factors such as
neurodegeneration and cognitive function (DeCarlo et al., 2014).
Within such a model, the cause of age-related cognitive slowing
is likely a complex cascade of processes. Declines in CPS have
been associated with genetic risk factors for Alzheimer’s disease
(AD) (Chibnik et al., 2011; Batterham et al., 2013), reduction of
white matter volume and integrity (Jokinen et al., 2007, 2012;
Kerchner et al., 2012), vascular health (Crichton et al., 2012;
Jacobs et al., 2013), chronic levels of systemic inflammation
(Bettcher et al., 2014; Palta et al., 2015), and levels of physical
activity (Lo et al., 2014; Nouchi et al., 2014).
Less well-understood is which factors drive changes in CPS
over time. We reasoned that studying the extremes of CPS change
over time provides an opportunity to understand the unique
health profile (genetic, biological, and behavioral factors) related
to its preservation and decline, some of which may be amenable
to change through lifestyle choices (Blazer et al., 2015). We
hypothesized that “resilient-agers” with unusually robust and
stable CPS over time would be associated with fewer genetic AD
risks, greater white matter health, lower levels of inflammation,
fewer cardiovascular risk factors, and increased rates of physical
activity.
MATERIALS AND METHODS
Subjects
This was an exploratory observational study conducted over
two time points. We started with a convenience sample of
165 neurologically and functionally intact older adults (aged
60 years and older) from existing research cohorts at the UCSF
Memory and Aging Center based on the availability of composite
CPS data. Each potential subject underwent a complete history,
neurological examination, a functional assessment, and an
hour-long neuropsychological screening battery, followed by a
consensus conference for the determination of diagnosis and
suitability for the study. Subject inclusion was based upon a
Mini-Mental State Exam score of >25 (Folstein et al., 1975), a
Clinical Dementia Rating score of zero, no symptoms of cognitive
impairment during the previous year as endorsed by either the
patient or informant, and no findings during examination that
raised concern for emerging cognitive decline. Exclusion criteria
included any contraindication to magnetic resonance imaging
(MRI), major psychiatric disorder, neurological conditions
affecting cognition (e.g., Parkinson’s disease, epilepsy), head
injury with loss of consciousness of 30-min or more, diagnosis
of MCI or dementia, history of brain tumor, sensory or motor
disability, active substance abuse, significant systemic medical
illnesses, current medications likely to affect CNS functions,
current depression (Geriatric Depression Scale Score greater
than 15 of 30), or insulin-dependent diabetes. Information
regarding medical history and medication use was secured via
participant self-report. All subjects continued to meet both
inclusion and exclusion criteria throughout the duration of the
study period. The UCSF committee on human research approved
the study, and all subjects provided written, IRB-approved
informed consent before participating.
Cognitive Processing Speed Testing
Each participant was administered a fixed battery of seven
visuospatial tasks, with tasks including between 1 and 4
conditions for a total of 14 task conditions (see Supplementary
Data Sheet 1). Administration time for the complete battery
was approximately 25 min. A scaled response latency z-score
for each task condition was calculated and compared to those
among a sample of young adult controls (n = 40; 16 males; age
24 ± 3.1 years; education 16 ± 1.6 years). The average of the
14 z-scores for each older subject yielded a composite z-score,
with higher scores denoting slower speed relative to the young
adult controls. This comparison of mean reaction times between
older subjects and younger controls has previously been validated
(Kerchner et al., 2012).
All task conditions were programmed on a PC using Eprime
software (Psychology Software Tools, Inc., Sharpsburg, PA,
USA1). Experiments were administered on a standard 15.4′′
Dell Latitude D830 laptop. Subjects were presented with stimuli
on the display and instructed to make visuospatial judgments.
Standard instructions were for subjects to respond as quickly
and accurately as possible. All tasks required a binary decision
(yes/no or left/right), and subjects were asked to use the index and
middle finger of their right hand to press the key on a keyboard
corresponding to their answer choice. Tasks commenced with
between 5 and 10 practice trials; if accuracy on these trials
fell below 70%, an additional round of practice trials was
administered before proceeding. The first two experimental trials
in each task condition served as ‘cushion’ trials and were not
included in the analyses. The median response latency of the
subsequent 20 experimental trials of each task condition was
recorded for analysis.
Processing Speed Change
We defined three CPS thresholds of change over two time
points in order to distinguish both fast and stable CPS,
1http://www.pstnet.com/eprime.cfm
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shown below in Figure 1. The battery of CPS tasks has been
described previously (see Supplemental Material) (Kerchner
et al., 2012). Resilient-agers included those individuals whose
baseline CPS performance was within 1.25 standard deviations
(SD) of the young adult comparison group. Baseline CPS
performance within 1.25 SD was the threshold for an above
average performance compared to the larger older adult cohort
(>75%). Additionally, resilient-agers changed no more than 0.5
SD at follow-up. A 0.5 SD cut-point in the observed distribution
has been employed as the minimally clinically important change
over time from baseline (Small et al., 2012; Brouillette et al., 2016).
A 0.5 SD change in CPS z-score corresponded to a 0.5 SD change
from baseline in the larger older adult cohort. Average-agers were
slower than the young controls at baseline (>1.25 SD) but also
changed no more than 0.5 SD at follow-up. Sub-agers were slower
than the young controls at baseline (>1.25 SD) and continued to
decline (>0.5 SD) at follow-up. From this sample we identified
120 subjects fitting our a priori baseline and follow-up CPS
parameters for resilient-agers, average-agers and sub-agers. These
criteria resulted in 17 resilient-agers, 56 average-agers, and 47
sub-agers. Mean length of follow-up was 2.5 (0.80) years. Baseline
CPS of average-agers and sub-agers was comparable to the larger
cohort of older adults from which they were drawn (n = 283;
z-score = 2.3 ± 1.4). Demographic variables are summarized in
Table 1.
Variables of Interest
Variables of interest representing both upstream and downstream
biological aging factors included genetics, white matter volume,
inflammatory markers, vascular risk factors, and lifestyle factors
that have been found to play a role in the slowing of CPS
among older adults. For genetics, we selected two well-established
AD risk genes. APOE was investigated due to the role of the
e4 allele as a risk factor for AD, and its association in the
FIGURE 1 | Cognitive processing speed (CPS) trajectories. aScaled
response latency composite z-score compared to those among a sample of
young adult controls (n = 40; age: 24 ± 3.1 years). Higher scores denote
slower speed relative to the young adult controls.
slowing of CPS (Bartzokis et al., 2007). CR1 was also investigated
given the A allele’s role as a risk factor for late-onset AD,
and its role in the acceleration of cognitive decline, including
declines in CPS (Lambert et al., 2009; Chibnik et al., 2011;
Sweet et al., 2012). Frequency of APOE and CR1 genotypes were
compared across groups. Our marker of white matter health
was calculation of total corpus callosum (CC) volume (sum
of posterior, mid-posterior, central, mid-anterior, and anterior
regional volumes), which has been associated with CPS in
older adults (Jokinen et al., 2007, 2012). The CC is the most
important commissural tract in the brain containing myelinated
axons transversing the subcortical white matter that mediate
the transfer and integration of sensory, cognitive, and motor
information between hemispheres. Studies have demonstrated
the relationship between CC volume and myelin integrity
(Hugenschmidt et al., 2008), and the relationship of each to
CPS (Fling et al., 2011; Kerchner et al., 2012). Our primary
marker of inflammation was calculation of peripheral level of
interleukin-6 (IL-6), which has been associated with declines
in CPS (Bettcher et al., 2014; Palta et al., 2015). Vascular risk
factors of interest demonstrating relationships with CPS include
measurement of body mass index (BMI), calculated as [weight
(kg)/height (m)2], low-density lipoprotein (LDL), high-density
lipoprotein (HDL), mean arterial pressure (MAP), calculated as
[(2 × diastolic)+systolic], and levels of fasting insulin (Yaffe
et al., 2004; Jefferson et al., 2015). Physical activity was calculated
by self-report using the Physical Activity Scale for the Elderly
(PASE), which asks subjects to recall their level of physical activity
over the previous 1 week (Forsen et al., 2010).
Laboratory Measures
Fasting blood samples were collected for estimation of HDL,
LDL, insulin, and genotyping. Plasma and serum separator tubes
were used to collect blood specimens. Tubes were left to clot at
room temperature for 30–60 min and placed into EDTA plasma
tubes. The blood was then centrifuged at 2500 rpm at room
temperature for 15 min. Plasma and serum were stored at−80◦C
until samples were analyzed. LDL, HDL, fasting glucose and
insulin samples were assessed in the UC Davis Medical Center
Clinical Laboratory. After fasting glucose and insulin samples
were collected, HOMA-IR ratio was computed as [(fasting insulin
(µU/mL) × fasting glucose (mg/dL))/405]. IL-6 was measured
using a Quantikine ELISA kit from R&D systems (Minneapolis,
MN, USA) in the laboratory of Dr. Ralph Green at the UC Davis
Medical Center (Sacramento, CA, USA).
Genotyping
Genomic DNA was extracted from peripheral blood using
standard protocols (Gentra PureGene Blood Kit, Qiagen,
Inc., Valencia, CA, USA). Genotyping was performed using
either TaqMan or Sequenom genotyping. TaqMan Allelic
Discrimination Assay was used for APOE genotyping (rs429358
and rs7412), and was conducted on an ABI 7900HT Fast
Real-Time PCR system (Applied Biosystems, Foster City, CA,
USA) according to manufacturer’s instructions. Sequenom iPLEX
Technology (Sequenom, San Diego, CA, USA) was used for CR1
genotyping (rs6656401). The SpectroAquire and MassARRAY
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TABLE 1 | Demographic, clinical, and health profile variables by CPS trajectory and effect size comparisons.
Resilient-agersa Average-agersa Sub-agersa Resilient vs. Averageb Resilient vs. Subsb Average vs. Subsb
Demographic/clinical characteristics
No. 17 56 47
Age, y 69.2 (0.96) (62–77) 70.9 (0.65) (63–79) 72.0 (0.68) (62–79) −0.38 −0.64 −0.23
Sex, % F 42 51 47
Education, y 18.4 (0.51) 17.7 (0.28) 17.4 (0.35) 0.33 0.44 0.13
GDS (total)e 2.6 (0.85) 2.5 (0.37) 3.1 (0.50) 0.03 −0.15 −0.20
MMSE (total)f 29.3 (0.24) 29.2 (0.11) 29.3 (0.15) 0.11 0.00 −0.11
CPS z-scores
Time 1 0.94 (0.06) 2.6 (0.14) 2.6 (0.18)
Time 2 0.99 (0.05) 2.3 (0.11) 3.7 (0.22)
Follow-up (years) 2.24 (0.22) 2.57 (0.11) 2.49 (0.11) −0.38 −0.30 0.10
Health profile variables
APOE e4 allele 59% (10) 32% (18) 23% (11) 0.61 0.85d 0.24
CR1 AA/AG allele 65% (11) 48% (25) 30% (14) 0.38 0.81c 0.43
CC volumeg 3101.3 (93.7) 2879.6 (51.2) 2803.1 (54.8) 0.58 0.78c 0.20
IL-6, pg/mlh 0.7 (0.21) 1.4 (0.22) 2.1 (0.35) −0.64 −0.94c −0.41
BMIi 23.8 (0.54) 25.0 (0.39) 25.9 (0.65) −0.48 −0.63 −0.25
Insulin (uU/ml)j 6.6 (0.83) 9.2 (0.89) 12.2 (1.4) −0.57 −0.84c −0.40
HDL-C (mg/dL)j 69.8 (4.1) 70.9 (3.3) 62.4 (4.0) −0.06 0.36 0.36
LDL-C (mg/dL)j 130.3 (9.8) 127.8 (6.3) 117.5 (5.6) 0.07 0.37 0.27
MAPk 146.6 (56.9) 149.3 (27.8) 152.5 (33.4) −0.01 −0.03 −0.01
PASEl 194.3 (23.5) 128.2 (9.5) 132.7 (11.1) 0.99d 0.87d −0.07
aValues are mean (SE); % (n); (range). Higher CPS z-scores represent worse performance. bValues are Cohen d effect size. cSignificant at threshold, p < 0.05. dSignificant
at threshold, p < 0.01. eGeriatric Depression Scale (GDS) scores range from 0 to 15 with higher scores indicating a greater number of depressive symptoms. fMini-mental
Status Examination (MMSE) scores range from 0 to 30 with lower scores indicating more significant cognitive deficits. gVolumetric data were available in a subsample of 16
Resilient-agers, 54 Average-agers, and 47 Sub-agers. h Interleukin-6 (IL-6) data were available in a subsample of 10 Resilient-agers, 39 Average-agers, and 34 Sub-agers.
iBody mass index (BMI) data were available in a subsample of 16 Resilient-agers, 52 Average-agers, and 42 Sub-agers. j Insulin and cholesterol data were available in
a subsample of 12 Resilient-agers, 43 Average-agers, and 39 Sub-agers. kMean arterial pressure (MAP) data were available in a subsample of 16 Resilient-agers, 56
Average-agers, and 46 Sub-agers. lPhysical Activity Scale for the Elderly (PASE) data were available in a subsample of 10 Resilient-agers, 37 Average-agers, and 30
Sub-agers. PASE scores range from 0 to 361 with higher scores indicating greater amounts of physical activity.
Typer Software packages (Sequenom, San Diego, CA, USA) were
used for interpretation and Typer analyzer (v3.4.0.18) was used
to review and analyze data.
Neuroimaging
Magnetic resonance imaging scanning was performed on a 3T
Siemens scanner (Siemens, Iselin, NJ, USA), using a protocol
that included a T1-weighted 3D MPRAGE sequence (TR/TE/TI
2300/3/900 ms; flip angle 9u; sagittal acquisition with FOV
2566240 mm2 and 1 mm thick slices; matrix 2566240 with 160
slices yielding 1 mm3 isotropic voxels). Structural MR images
were analyzed using the FreeSurfer image analysis suite2. After
initial automated segmentation through FreeSurfer version 5.1,
each subject’s image was individually checked for quality and
accuracy of segmentation. Remaining inaccuracies in either gray
and white matter segmentation or pial boundaries and residual
skull fragments were manually corrected with FreeSurfer’s built-
in editing software. These cases were reprocessed and final
volumes were recalculated. Intracranial volume (ICV) was
calculated based on FreeSurfer’s own eTIV (estimated total ICV)
metric, which uses atlas normalization as well as the relationship
2http://surfer.nmr.mgh.harvard.edu
between the linear transform to MNI305 space and ICV. Region
of interest was the CC (Fischl et al., 2002).
Data Analysis
Statistical analyses were performed using PASW 21.0 for Mac
(SPSS, Inc., Chicago, IL, USA). Demographic variables were
compared using analysis of variance with chi square for
dichotomous variables and Tukey post hoc tests and α = 0.05.
General linear models were performed to determine group
differences in variable scores of interest. Pairwise comparisons
with Tukey post hoc analysis were used to evaluate differences
among adjusted means. Bonferroni correction was used to
evaluate differences among adjusted means for genotyping and
neuroanatomical models. p-values < 0.05 for these comparisons
were considered significant. The number of genetic and
vascular measures investigated was not corrected for multiple
comparisons. Given the exploratory nature of this study, and
the limited corpus of literature on this topic, we chose to risk
an increase in type I errors over type II errors. A multinomial
logistic regression with CPS groups as the dependent variable
and significant clinical variables as the predictors was performed
to determine which clinical variables, if any, predicted CPS
groups.
Frontiers in Aging Neuroscience | www.frontiersin.org 4 March 2017 | Volume 9 | Article 55
fnagi-09-00055 March 8, 2017 Time: 17:26 # 5
Bott et al. CPS Trajectories in Aging
RESULTS
There were no group differences in age, sex, or education. The
raw mean scores, SD, and effect sizes of test performance by
group for all demographic, clinical, and health profile variables
are presented in Table 1. Graphical representation of significant
health profile variables is presented in Figure 2.
APOE and CR1 Genotyping
Analysis of APOE e4 allelic frequency revealed that of the 17
resilient-agers, 10 (59%) had an e4 allele. In contrast, only 18
average-agers (32%) and 11 sub-agers (23%) had an e4 allele.
Chi square analysis of APOE e4 allele frequency was significant
(χ2 = 7.15; p = 0.028) with greater frequency of an e4 allele
in the resilient-agers than sub-agers. Analysis of CR1 rs6656401
AA/AG allelic frequency revealed that of the 17 resilient-agers, 11
(65%) had AA/AG alleles, versus 6 (35%) with the GG allele. In
contrast, only 25 average-agers (48%) and 14 sub-agers (30%) had
AA/AG alleles. Chi square analysis of AA/AG allelic frequency
was significant (χ2 = 7.16; p = 0.028) with greater frequency of
AA/AG alleles in the resilient-agers than sub-agers. Descriptive
analysis of the 17 resilient-agers revealed that 7 (41%) were
carriers of both CR1 AA/AG alleles and the APOE e4 allele.
Baseline Corpus Callosum Volume
Resilient-agers had larger CC volume at baseline than sub-agers
(p < 0.05). There was no difference in CC volume between
resilient-agers and average-agers.
Baseline Level of Peripheral
Inflammation
Resilient-agers exhibited lower levels of IL-6 at baseline than sub-
agers (p < 0.05). There was no difference in IL-6 levels between
resilient-agers and average-agers.
FIGURE 2 | Mean, standard error, and frequencies of health profile variable scores. (A) Baseline physical activity: ∗ resilient-agers > average-agers and
sub-agers. (B) Genotype frequency %: ∗ resilient-agers > sub-agers. (C) Baseline corpus callosum volume: ∗ resilient-agers > sub-agers. (D) Baseline levels of IL-6:
∗ resilient-agers < sub-agers. (E) Baseline levels of insulin: ∗ resilient-agers < sub-agers.
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Baseline Cardiovascular Risk Measures
No differences between groups were observed on baseline levels
of BMI, HDL, LDL, or MAP. Resilient-agers exhibited lower
levels of fasting insulin than sub-agers (p < 0.05). There was no
difference in insulin level between resilient-agers and average-
agers.
Baseline Physical Activity Level
Resilient-agers reported more activity than both average- and
sub-agers, endorsing more physical activity on the PASE at
baseline (p < 0.01).
Secondary Analysis
To further explore the contributions of these factors we
constructed a multinomial logistic forced entry regression with
the three CPS groups as the dependent variable and all
significant continuous outcome variables as predictors (PASE,
insulin, IL-6, and CC volume). We also included age as
a covariate. Due to availability of data for the significant
outcome variables, the sample size for this model included
seven resilient-agers, 27 average-agers, 22 sub-agers. The
multinomial logistic regression indicated that the overall model
was significant (p = 0.024; Nagelkerke pseudo-R2 = 0.358).
Likelihood ratio tests indicated that IL-6 [χ2(2,56) = 7.20;
p = 0.027)] and PASE [χ2(2,56) = 6.16; p = 0.046)] were
significant predictors. Parameter estimates with resilient-agers
as the reference group indicated PASE as a significant predictor
with respect to average-agers [χ2(1,27) = 4.60; unstandardized
beta = −0.019; 95% CI = 0.963 to 0.968; p = 0.032]. Parameter
estimates with resilient-agers as the reference group indicated
PASE [χ2(1,22) = 4.20; unstandardized beta = −0.019; 95%
CI = 0.963 to 0.999; p = 0.040] and IL-6 [χ2(1,22) = 3.90;
unstandardized beta = 1.64; 95% CI = 1.011 to 26.28;
p = 0.048] as significant predictors with respect to sub-
agers.
DISCUSSION
In the present exploratory study we defined and identified three
CPS change thresholds in older adults based upon baseline and
2.5-year follow-up CPS performance. The major findings of this
paper are that when compared with average- and sub-agers,
resilient-agers endorsed more physical activity at baseline, and
exhibited lower levels of IL-6 and fasting insulin, and larger total
CC volume than sub-agers at baseline. Contrary to expectations,
we observed a higher frequency of two AD risk alleles, APOE
e4 and CR1 AA/AG, in the resilient-agers than in the sub-
agers.
Our findings are consistent with reports highlighting the role
of chronic low-grade inflammation in cognitive aging processes
(Bettcher and Kramer, 2013; Franceschi and Campisi, 2014).
Specifically, circulating levels of IL-6 increase with age (Albani
et al., 2009) and have been associated with rate of cognitive
decline in older adults (Yaffe et al., 2004; Dik et al., 2005;
Mooijaart et al., 2013). An inverse relationship between IL-6
and CC fractional anisotropy has been reported, the effect of
which increased with age in typically aging older adults. This
cross-sectional study also reported that higher levels of IL-6
were related to slower processing speed (Bettcher et al., 2014).
This is the first study to demonstrate the role of IL-6 on speed
of cognitive processing over time in a sample of older adults.
Moreover, the results of the multinomial regression suggest that
IL-6 may play a particularly significant role in the maintenance of
CPS.
The role of vascular factors in driving cognitive decline
in healthy and pathological populations has a growing body
of support (Crichton et al., 2012). Insulin resistance (fasting
insulin and HOMA-IR) has previously been associated with
declines in cognition in middle-aged and older adults, including
slower CPS (Laakso, 1993; Young et al., 2006; Tan et al.,
2011; Frazier et al., 2015). It is reasonable to hypothesize that
insulin resistance may contribute to slower processing speed via
changes in white matter integrity. A recent study reported that
greater insulin resistance as measured by HOMA-IR levels was
associated with alterations on diffusion tensor imaging (DTI) in
the CC and connection tracts in frontal white matter (Ryu et al.,
2014). Although we cannot determine the causal nature of this
association, this study extends the relationship between measures
of insulin resistance and CPS to include typically aging older
adults.
The relationships between preserved volume and white matter
integrity of the CC and CPS have also demonstrated robust
positive associations (Jokinen et al., 2007, 2012; Kerchner et al.,
2012). Overall CC atrophy is associated with slower CPS
in older adults with age-related white matter hyperintensities
(Jokinen et al., 2007), and CC volume loss over a 3-year period
predicted longitudinal slowing of CPS in older adults with
age-related white matter hyperintensities (Jokinen et al., 2012).
The current study provides evidence for the relationship of
whole CC volume and CPS over time in a sample of typically
aging older adults, providing support for whole CC volume
as a proxy of white matter health that predicts change over
time.
The positive effects of physical activity on cognitive
functioning in healthy older adults, including CPS, have
been well-documented (Barnes et al., 2003; Kelly et al., 2014).
This study extends these findings, providing evidence that
physical activity is associated with robust and stable CPS over
time. Although we are not the first to show the beneficial effects
of physical activity (Lo et al., 2014; Nouchi et al., 2014), these
results offer preliminary evidence that physical activity plays
a particularly significant role in the maintenance of CPS over
time.
Our finding that two AD risk genes were disproportionally
represented in our resilient-agers was surprising. This may be
due in part to the small number of subjects meeting criteria
as a resilient-ager. Given the roles that APOE e4 and CR1
AA/AG alleles have been reported to play in the deposition
of β-amyloid, the breakdown of myelin and cognitive decline
(Bartzokis et al., 2007; Lambert et al., 2009; Chibnik et al., 2011),
the preponderance of these risk alleles may further suggest the
presence of a survival effect among this cohort. While each of
these genetic variants confer risk, neither is fully penetrant in
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its risk effect, and may indicate that individuals in the resilient-
ager cohort were never at risk. Furthermore, recent studies
investigating the relationship between CR1 and APOE found
no evidence for an interaction effect conferring additional risk
for AD (Carrasquillo et al., 2011). Thambisetty et al. (2013)
recently reported that among non-demented older adults, similar
amyloid burden was observed among APOE e4 carriers and
non-carriers, who were also carriers of CR1 AA/AG alleles.
The relatively high co-occurrence of APOE e4 carriers and CR1
AA/AG carriers in the resilient-ager group stands in accord with
these results. On the other hand, these results may suggest the
presence of protective factors within the resilient-ager cohort,
mitigating the effects of cognitive decline associated with these
alleles.
One such potential factor is completed years of education.
Kaup et al. (2015) found that among community-dwelling older
black and white APOE e4 carriers, higher educational level
predicted cognitive resilience. While each of the three groups
in this study had similar years of completed education, the
resilient-ager group reported the highest (mean= 18.4). Physical
activity is another factor that has been studied in healthy older
adult APOE e4 carriers. Smith et al. (2016) recently reported
that APOE e4 carriers reporting high amounts of leisure time
physical activity demonstrated greater white matter integrity
(lower fractional anisotropy and greater radial diffusivity) than
APOE e4 carriers reporting low physical activity. These results
suggest that physical activity among APOE e4 carriers may offer
unique protective effects against white matter demyelination,
which in turn could contribute to the maintenance of CPS. While
the finding in this study needs replication, it opens exciting lines
of inquiry to further examine whether the factors identified in
this study or other factors may modify the effects of these genetic
risk factors, providing protective effects in the presence of genetic
predisposition toward neuropathology.
Results from this study underscore the heterogeneity of
cognitive aging even among typically aging older adults.
Recent advances in biological aging models posit a multi-
determined, mechanistic account of biological aging, with the
causal factors of environment, lifestyle factors, genetics, and
disease interacting with redox balance, inflammatory status,
and vascular health to affect aging, cognitive function, and
neurodegeneration (DeCarlo et al., 2014). While our study
design does not provide for the analysis or conclusion of
the effects of specific variables on others, within such a
model, physical activity (PASE) and genotype (APOE, CR1)
represent upstream causal mechanisms with downstream effects
on vascular health (insulin resistance) and inflammatory
measures (IL-6), which in turn have downstream effects on
neurodegeneration (CC volume) and cognitive function (CPS).
A strength of the current study is the robust measure of CPS,
incorporating 14 task conditions. This method represents a
more valid measure of CPS than most studies investigating
CPS, which make use of a single measure of CPS (Sheppard
and Vernon, 2008). The composite CPS measure used in this
study may be particularly well-suited for studies investigating
the role of physical exercise or inflammatory processes in older
adults.
We acknowledge several limitations of this study. The
sample size was relatively small, particularly the cohort of
resilient-agers. While by definition this group will likely
be smaller, future studies should seek to identify a larger
number of these resilient-agers. The majority of our findings
dissociated resilient-agers and sub-agers, and these results may
reflect differences between normal and abnormal cognitive
decline. On the other hand, results of the CC volume, IL-
6, and insulin data demonstrated numeric differences and
medium effect sizes between the resilient-ager and average-
ager groups, so the lack of statistical significance may be an
issue of power. We did not incorporate multimodal imaging
such as amyloid and tau imaging, or DTI, which would have
provided more robust measures of white matter integrity.
Our measures of cardiovascular health and inflammation
were also limited and the overall impact of these factors on
CPS may be even greater. The secondary regression analysis
included a reduced sample, which could affect the stability
of the model. This initial study included measurement of
CPS over time, but we did not investigate longitudinal
change in other variables of interest. While the findings
in this small group of resilient-agers offers validity to the
characterization of unusually successful domain-specific
cognitive aging, future studies including more time points and
investigating additional cognitive domains will allow for distinct
longitudinal aging trajectories to be plotted and more robustly
characterized.
The current study adds to a growing body of literature
identifying subgroups of older adults that demonstrate uniquely
strong domain-specific cognitive abilities that resist age-
related cognitive decline. “Super-agers” have previously been
characterized in individuals over age 80 with episodic memory
performance at least as good as normative values for 50-
to 65-year-olds (Rogalski et al., 2013; Gefen et al., 2014,
2015; Sun et al., 2016). This is the first study to our
knowledge characterizing older adults who resist age-related
change in domains other than episodic memory. While CPS
represents a circumscribed cognitive domain, domain-specific
cognitive aging has been reported to predict functional decline
better than global cognition in elderly populations (Johnson
et al., 2007). CPS also plays a mediating role across other
cognitive domains including memory and fluid reasoning
(Salthouse, 1996). Moreover, slower CPS is associated with
functional decline, and serves as a unique early predictor
of neurodegenerative processes such as AD (Triebel et al.,
2014). Studies investigating unusually successful domain-specific
cognitive aging provide a unique opportunity to identify factors
that promote healthy cognitive aging trajectories, which may lead
to novel interventions for the prevention of age-related cognitive
decline.
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